India’s health ministry bans pioglitazone, metamizole, and flupentixol-melitracen

India’s ministry of health and family welfare has banned the popular diabetes drug pioglitazone, the painkiller metamizole, and the psychiatric combination flupentixol with melitracen with immediate effect, because it said that their use was “likely to involve risk to human beings.”

The move is a response to a report from a parliamentary standing committee in April that criticised the ministry for failing to withdraw several drugs …

Read full article by Dr Soumyadeep B at British Medical Journal

Related : Committee condemns Indian government for failing to withdraw 33 drugs that lack evidence

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s